Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:38 AM
Ignite Modification Date:
2025-12-25 @ 3:38 AM
NCT ID:
NCT06647602
Eligibility Criteria:
Inclusion Criteria:
* Histologically confirmed DTC (papillary thyroid carcinoma, follicular thyroid carcinoma, oncocytic thyroid carcinoma)
* Classified as high-risk DTC according to the ATA guidelines (1) or, patients for whom the risk of a recurrence is estimated to be higher based on clinical features (assessed by their treating physician).
* Prepared for RAI-therapy with TH-withdrawal
* Patients have to be fit to adhere to the study protocol
* Patients have to be able to read and understand the Dutch language
Exclusion Criteria:
* Pregnancy
* Patients with a psychiatric history or history of depression
* Patients with comorbidities, such as severe heart failure, (poorly controlled) atrial fibrillation, of which the treating physician decides that L-T3 is unsuitable.
Conditions or drugs interfering with thyroid hormone uptake:
\- Patients with a history of atrophic gastriti
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT06647602
Study Brief:
Protocol Section:
NCT06647602